Header cover image

South Korean (KOSPI) Clinical Research and Equipment Industry Analysis

UpdatedMay 28, 2024
DataAggregated Company Financials
Companies32
  • 7D-4.4%
  • 3M-5.0%
  • 1Y-0.8%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 4.4%, driven by a pullback from Samsung BiologicsLtd of 4.2%. Meanwhile, Peptron actually outperformed within the industry, gaining 16% in the last week. Over the last year, the industry has been flat overall. Looking forward, earnings are forecast to grow by 15% annually.

Industry Valuation and Performance

Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 28 May 2024₩59.3t₩4.6t₩698.0b19x84.9x12.8x
Thu, 25 Apr 2024₩63.7t₩4.7t₩654.7b19.8x97.3x13.7x
Sat, 23 Mar 2024₩66.7t₩4.6t₩656.5b19.8x101.6x14.4x
Mon, 19 Feb 2024₩64.6t₩4.5t₩714.4b33.9x90.4x14.3x
Wed, 17 Jan 2024₩60.4t₩4.5t₩721.5b32.5x83.7x13.3x
Fri, 15 Dec 2023₩55.6t₩4.5t₩721.5b31x77.1x12.3x
Sun, 12 Nov 2023₩57.0t₩4.4t₩660.9b21.7x86.2x13x
Tue, 10 Oct 2023₩57.8t₩4.4t₩660.9b29.9x87.5x13.2x
Thu, 07 Sep 2023₩58.0t₩4.4t₩660.0b25.7x87.9x13.2x
Sat, 05 Aug 2023₩62.0t₩4.2t₩673.4b28.9x92.1x14.8x
Mon, 03 Jul 2023₩58.1t₩4.2t₩673.4b30.3x86.3x13.9x
Wed, 31 May 2023₩60.9t₩4.3t₩612.9b33.1x99.4x14.2x
Fri, 28 Apr 2023₩60.7t₩4.1t₩626.3b27.2x97x14.9x
Sun, 26 Mar 2023₩61.8t₩4.0t₩717.2b26x86.2x15.3x
Tue, 21 Feb 2023₩62.9t₩3.5t₩427.8b21.6x147.1x18.1x
Thu, 19 Jan 2023₩61.9t₩3.5t₩426.6b19.8x145.1x17.8x
Sat, 17 Dec 2022₩65.2t₩3.4t₩428.7b24.3x152x19x
Mon, 14 Nov 2022₩69.6t₩3.0t₩448.5b23.8x155.2x23.3x
Wed, 12 Oct 2022₩62.3t₩3.0t₩448.5b21.7x138.8x20.9x
Fri, 09 Sep 2022₩63.9t₩3.0t₩448.7b28.5x142.4x21.4x
Sun, 07 Aug 2022₩71.1t₩2.7t₩454.7b28.8x156.3x26.2x
Tue, 05 Jul 2022₩62.4t₩2.7t₩454.7b27.5x137.3x23x
Thu, 02 Jun 2022₩67.3t₩2.7t₩456.1b27x147.6x24.9x
Sat, 30 Apr 2022₩66.4t₩2.4t₩379.4b23x174.9x27.4x
Mon, 28 Mar 2022₩61.1t₩2.4t₩390.9b23.9x156.4x25.3x
Wed, 23 Feb 2022₩57.1t₩2.4t₩409.6b24.7x139.5x24.3x
Fri, 21 Jan 2022₩61.4t₩2.3t₩412.7b25.5x148.7x26.1x
Sun, 19 Dec 2021₩71.2t₩2.3t₩412.7b29.1x172.4x30.3x
Tue, 16 Nov 2021₩64.2t₩2.1t₩329.9b25.1x194.5x29.9x
Thu, 14 Oct 2021₩61.8t₩2.1t₩329.9b26x187.2x28.7x
Sat, 11 Sep 2021₩69.4t₩2.2t₩330.9b35.9x209.8x31.4x
Mon, 09 Aug 2021₩68.5t₩2.2t₩336.8b35x203.5x31x
Price to Earnings Ratio

259.8x


Total Market Cap: ₩64.3tTotal Earnings: ₩247.5bTotal Revenue: ₩2.1tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Clinical Research and Equipment Industry Price to Earnings3Y Average 135.1x202220232024
Current Industry PE
  • Investors are pessimistic on the South Korean Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 84.9x which is lower than its 3-year average PE of 135x.
  • The 3-year average PS ratio of 20.6x is higher than the industry's current PS ratio of 12.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 41% per year over the last three years.
  • Revenues for these companies have grown 31% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does South Korean Clinical Research and Equipment compare with similar industries?

KR Market-0.56%
Healthcare-2.58%
Life Sciences-4.38%
Clinical Research and Equipment-4.38%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A087010 Peptron₩36.80k21.7%
+₩135.1b		384.8%PS285.8x
A220100 FutureChemLtd₩16.24k15.9%
+₩49.3b		112.6%PS25.7x
A278650 HLB bioStepLtd₩2.69k2.9%
+₩6.4b		-38.1%PS4.6x
A347740 P&K Skin Research Center₩2.94k1.2%
+₩1.1b		-8.7%PE18.3x
A258540 SL Therapeutics₩892.0019.3%
+₩750.8m		-55.3%n/a
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A207940

₩745,000.00

Samsung BiologicsLtd

7D

-4.4%

1Y

-4.2%

Does Samsung BiologicsLtd (KRX:207940) Have A Healthy Balance Sheet?

May 27
Does Samsung BiologicsLtd (KRX:207940) Have A Healthy Balance Sheet?

A141080

₩63,400.00

LigaChem Biosciences

7D

-9.4%

1Y

57.9%

Here's Why LigaChem Biosciences (KOSDAQ:141080) Can Manage Its Debt Despite Losing Money

May 23
Here's Why LigaChem Biosciences (KOSDAQ:141080) Can Manage Its Debt Despite Losing Money

A278650

₩2,685.00

HLB bioStepLtd

7D

2.9%

1Y

-38.1%

HLB bioStep Co.,Ltd. (KOSDAQ:278650) Shares May Have Slumped 33% But Getting In Cheap Is Still Unlikely

May 22
HLB bioStep Co.,Ltd. (KOSDAQ:278650) Shares May Have Slumped 33% But Getting In Cheap Is Still Unlikely

A223250

₩3,325.00

DreamCIS

7D

-7.8%

1Y

4.7%

A220100

₩16,240.00

FutureChemLtd

7D

15.9%

1Y

112.6%

FutureChem Co.,Ltd (KOSDAQ:220100) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Apr 29
FutureChem Co.,Ltd (KOSDAQ:220100) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

A445680

₩48,600.00

Curiox Biosystems

7D

-7.1%

1Y

n/a

A347740

₩2,935.00

P&K Skin Research Center

7D

1.2%

1Y

-8.7%

We Think That There Are More Issues For P&K Skin Research Center (KOSDAQ:347740) Than Just Sluggish Earnings

Mar 28
We Think That There Are More Issues For P&K Skin Research Center (KOSDAQ:347740) Than Just Sluggish Earnings

A238120

₩4,065.00

Aligned Genetics

7D

-8.7%

1Y

0.7%

A087010

₩36,800.00

Peptron

7D

21.7%

1Y

384.8%

Does Peptron (KOSDAQ:087010) Have A Healthy Balance Sheet?

Feb 26
Does Peptron (KOSDAQ:087010) Have A Healthy Balance Sheet?

A217950

₩28,700.00

PHARMARESEARCH BIO

7D

-4.8%

1Y

47.3%

A383930

₩8,370.00

DT&CRO

7D

-5.2%

1Y

53.3%

A236340

₩5,050.00

MEDIZEN HUMANCARE

7D

2.0%

1Y

-6.5%

A038290

₩20,750.00

Macrogen

7D

-6.1%

1Y

5.0%

A246250

₩4,725.00

SLS BIO

7D

0.5%

1Y

-38.8%

A258540

₩892.00

SL Therapeutics

7D

19.3%

1Y

-55.3%